CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
about
Pathways to precision medicine in smoking cessation treatments.A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems.Perceptions of pharmacogenetic research to guide tobacco cessation by patients, providers and leaders in a tribal healthcare setting.Distinctiveness of the Roma population within CYP2B6 worldwide variation.Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.Effects of Genetic Polymorphisms of CYP2B6 on the Pharmacokinetics of Bupropion and Hydroxybupropion in Healthy Chinese Subjects.
P2860
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@en
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@nl
type
label
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@en
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@nl
prefLabel
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@en
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@nl
P2093
P2860
P1476
CYP2B6 rs2279343 polymorphism ...... success in bupropion therapy.
@en
P2093
Alexandre Costa Pereira
Jaqueline Scholz Issa
Juliana Rocha Santos
Patrícia Viviane Gaya
Paulo Caleb Júnior Lima Santos
Paulo Roberto Xavier Tomaz
Tânia Ogawa Abe
P2860
P2888
P304
P356
10.1007/S00228-015-1896-X
P577
2015-07-08T00:00:00Z